Atlas Trials

Cadonilimab in Combination With Ramucirumab for the Treatment of Advanced Hepatocellular Carcinoma That Has Failed at Systemic Therapy

Clinical trial NCT05856864 · UNKNOWN

Trial details

NCT number
NCT05856864
Sponsor
Tianjin Medical University Cancer Institute and Hospital
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Hepatocellular Carcinoma That Has Failed at Systemic Therapy
Start date
2024-06-01
Primary completion
2024-07-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.